Brexanolone as adjunctive therapy in super‐refractory status epilepticus
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Neurology"
DOI: 10.1002/ana.25008
Abstract: Super‐refractory status epilepticus (SRSE) is a life‐threatening form of status epilepticus that continues or recurs despite 24 hours or more of anesthetic treatment. We conducted a multicenter, phase 1/2 study in SRSE patients to evaluate… read more here.
Keywords: status; brexanolone adjunctive; refractory status; status epilepticus ... See more keywords